Home  »  Company  »  Suven Pharmaceuticals Ltd.  »  Quotes  »  Audited Results
Enter the first few characters of Company and click 'Go'

Audited Results of Suven Pharmaceuticals Ltd. Company

(Rs in Cr.) Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019
Operating Income 1,330.08 1,320.22 1,009.72 833.79 377.83
Manufacturing Expenses 168.93 170.74 120.98 104.80 50.77
Personnel Expenses 100.84 100.48 87.29 73.72 29.63
Selling Expenses 0 0 0 0 0
Administrative Expenses 74.87 67.46 57.23 39.98 22.15
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 747 740.23 569.20 448.64 206.28
Operating Profit 583.08 579.99 440.52 385.15 171.55
Other Recurring Income 44.55 187.79 14.24 18.12 0.60
Adjusted PBDIT 627.63 767.78 454.76 403.26 172.15
Financial Expenses 5.39 6.23 9.14 21.81 2.79
Depreciation 42.84 39.10 31.64 23.86 11.50
Other Write offs 0 0 0 0 0
Adjusted PBT 579.39 722.45 413.98 357.59 157.87
Tax Charges 146.79 164.35 105.33 87.51 48.59
Adjusted PAT 432.60 558.10 308.65 270.08 109.27
Non Recurring Items -0.35 -0.76 0 -0.82 0
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 432.60 558.10 308.65 270.08 109.27
Equity Dividend 203.65 101.83 25.46 50.56 15.17
Preference Dividend 0 0 0 0 0
Retained Earnings 1,504.98 1,291.39 851.71 596.60 409.91
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X